Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Therapie
|
May 2, 2020
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study
Canelle Mazaud, Laurence Fardet
Presse Medicale (Paris, France : 1983)
|
July 1, 2005
[Heerfordt's syndrome]
Laurence Fardet, Alain Dupuy
Acta Dermato-Venereologica
|
February 14, 2018
Folate Supplementation During Methotrexate Therapy: A Population-based Retrospective Cohort Study
Canelle Mazaud, Laurence Fardet
Clinical Rheumatology
|
May 10, 2015
Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients
Clément Morin, Laurence Fardet
Drugs
|
September 11, 2014
Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events
Laurence Fardet, Bruno Fève
Presse Medicale (Paris, France : 1983)
|
October 25, 2002
[Non-selective and selective non-steroidal anti-inflammatory drugs, administration in pregnancy and breast feeding]
Laurence Fardet, Jacky Nizard, Thierry Généreau
Plos Medicine
|
May 25, 2016
Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study
Laurence Fardet, Irene Petersen, Irwin Nazareth
Annals of the Rheumatic Diseases
|
October 20, 2018
Response to: 'Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease' by Lee
Laurence Fardet, Irene Petersen, Irwin Nazareth
BMJ (Clinical Research Ed.)
|
August 1, 2012
Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study
Laurence Fardet, Irene Petersen, Irwin Nazareth
Annals of the Rheumatic Diseases
|
September 2, 2019
Response to: 'Chronic hydroxychloroquine exposure and the risk of Alzheimer's disease' by Lai <i>et al</i>
Laurence Fardet, Irene Petersen, Irwin Nazareth
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Therapie
|
May 2, 2020
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study
Canelle Mazaud, Laurence Fardet
Presse Medicale (Paris, France : 1983)
|
July 1, 2005
[Heerfordt's syndrome]
Laurence Fardet, Alain Dupuy
Acta Dermato-Venereologica
|
February 14, 2018
Folate Supplementation During Methotrexate Therapy: A Population-based Retrospective Cohort Study
Canelle Mazaud, Laurence Fardet
Clinical Rheumatology
|
May 10, 2015
Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients
Clément Morin, Laurence Fardet
Drugs
|
September 11, 2014
Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events
Laurence Fardet, Bruno Fève
Presse Medicale (Paris, France : 1983)
|
October 25, 2002
[Non-selective and selective non-steroidal anti-inflammatory drugs, administration in pregnancy and breast feeding]
Laurence Fardet, Jacky Nizard, Thierry Généreau
Plos Medicine
|
May 25, 2016
Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study
Laurence Fardet, Irene Petersen, Irwin Nazareth
Annals of the Rheumatic Diseases
|
October 20, 2018
Response to: 'Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease' by Lee
Laurence Fardet, Irene Petersen, Irwin Nazareth
BMJ (Clinical Research Ed.)
|
August 1, 2012
Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study
Laurence Fardet, Irene Petersen, Irwin Nazareth
Annals of the Rheumatic Diseases
|
September 2, 2019
Response to: 'Chronic hydroxychloroquine exposure and the risk of Alzheimer's disease' by Lai <i>et al</i>
Laurence Fardet, Irene Petersen, Irwin Nazareth
Page
of 8